The Benign Prostatic Hyperplasia (Bph) Treatment Devices and Equipment Market is valued at USD 2.3 billion in 2025 and is projected to grow at a CAGR of 7.1% to reach USD 4.3 billion by 2034.
The benign prostatic hyperplasia (BPH) treatment devices and equipment market addresses a prevalent condition among aging men that causes prostate gland enlargement, leading to uncomfortable urinary symptoms. Traditional treatment options include medications, minimally invasive procedures, and surgical interventions, each with varying levels of effectiveness and side effects. The market for BPH treatment devices has grown significantly due to advances in technology, patient preference for less invasive solutions, and the increasing prevalence of BPH worldwide.
Among the most notable advancements are innovative minimally invasive devices such as laser-based systems, prostatic urethral lift implants, and water vapor therapy devices. These technologies offer shorter recovery times, fewer complications, and reduced need for hospitalization compared to traditional surgical approaches. Additionally, image-guided and robotic-assisted techniques have enhanced the precision and safety of BPH procedures, improving patient outcomes and satisfaction. As a result, more patients and healthcare providers are opting for these cutting-edge solutions.
Regionally, North America leads the market due to the high prevalence of BPH, well-established healthcare infrastructure, and rapid adoption of advanced medical technologies. Europe and Asia-Pacific are also witnessing steady growth, driven by rising healthcare awareness, increased access to medical facilities, and an aging population. As awareness of BPH treatment options grows and technology continues to improve, the market for BPH treatment devices and equipment is poised for sustained expansion.
Macroeconomic indicators, policy frameworks such as carbon pricing and energy security strategies, and evolving consumer behavior are considered in forecasting scenarios. Recent deal flows, partnerships, and technology innovations are incorporated to assess their impact on future market performance.
Regional insights highlight the most promising investment destinations, regulatory landscapes, and evolving partnerships across energy and industrial corridors.
This product will be delivered within 1-3 business days.
The benign prostatic hyperplasia (BPH) treatment devices and equipment market addresses a prevalent condition among aging men that causes prostate gland enlargement, leading to uncomfortable urinary symptoms. Traditional treatment options include medications, minimally invasive procedures, and surgical interventions, each with varying levels of effectiveness and side effects. The market for BPH treatment devices has grown significantly due to advances in technology, patient preference for less invasive solutions, and the increasing prevalence of BPH worldwide.
Among the most notable advancements are innovative minimally invasive devices such as laser-based systems, prostatic urethral lift implants, and water vapor therapy devices. These technologies offer shorter recovery times, fewer complications, and reduced need for hospitalization compared to traditional surgical approaches. Additionally, image-guided and robotic-assisted techniques have enhanced the precision and safety of BPH procedures, improving patient outcomes and satisfaction. As a result, more patients and healthcare providers are opting for these cutting-edge solutions.
Regionally, North America leads the market due to the high prevalence of BPH, well-established healthcare infrastructure, and rapid adoption of advanced medical technologies. Europe and Asia-Pacific are also witnessing steady growth, driven by rising healthcare awareness, increased access to medical facilities, and an aging population. As awareness of BPH treatment options grows and technology continues to improve, the market for BPH treatment devices and equipment is poised for sustained expansion.
Key Insights: Benign Prostatic Hyperplasia (Bph) Treatment Devices and Equipment Market
- Increasing preference for minimally invasive procedures that offer quick recovery and fewer complications.
- Development of advanced laser technologies and water-based therapies for more effective symptom relief.
- Integration of robotic-assisted systems and image-guided techniques for enhanced precision and safety.
- Growing prevalence of BPH among aging male populations worldwide.
- Rising patient awareness about advanced treatment options and their benefits.
- Ongoing innovation in device technology and procedural techniques, leading to improved patient outcomes.
- High costs associated with advanced treatment devices and equipment, which may limit accessibility for some patients.
- Potential side effects and complications from certain procedures, requiring thorough patient screening and counseling.
- Limited access to skilled medical professionals trained in the use of new devices and techniques, particularly in developing regions.
Benign Prostatic Hyperplasia (Bph) Treatment Devices and Equipment Market Segmentation
By Product
- Resectoscopes
- Radiofrequency Ablation Device
- Urology Lasers
- Prostatic Stents
- Implants
By Procedure Type
- Transurethral Needle Ablation (TUNA)
- Transurethral Resection Of Prostate (TURP)
- Transurethral Incision Of Prostate (TUIP)
- Transurethral Microwave Thermotherapy (TUMT)
- Laser Surgery
- Other Procedure Types
By End-User
- Hospitals
- Ambulatory Surgical Centres (ASC)
- Clinics
- Home
Key Companies Analysed
- Karl Storz
- Lumenis Ltd.
- Olympus Corporation
- Urologix LLC
- Boston scientific Inc.
- Endo International plc
- NeoTract Inc.
- OmniGuide Inc.
- Medifocus Inc.
- ProArc Medical Ltd.
- Teleflex Incorporated
- Medtronic plc
- Urotech Devices
- Prostalund Operations AB
- Baxter International
- NxThera Inc.
- Richard Wolf GmbH
- Coloplast A/S
- Siemens Healthineers
- Quest Pharmatech
- Protox Therapeutics
- IntelGenx Technologies Corp
- Astellas Pharma Inc.
- Ipsen S.A.
- Biolitec AG
- BVM Medical
- Convergent Laser Technologies
- Cook Medical
- GreenLight Technologies
- Merit Medical Systems
- Pnn Medical A/S
- PROCEPT BioRobotics
- Prosenex
- ProSolv CardioVascular Inc.
- Quanta System
- Rocamed SAM
- RZ Medizintechnik GmbH
- SRS Medical Systems
- UroShape LLC
- Vertebron Inc.
Benign Prostatic Hyperplasia (Bph) Treatment Devices and Equipment Market Analytics
The report employs rigorous tools, including Porter’s Five Forces, value chain mapping, and scenario-based modeling, to assess supply-demand dynamics. Cross-sector influences from parent, derived, and substitute markets are evaluated to identify risks and opportunities. Trade and pricing analytics provide an up-to-date view of international flows, including leading exporters, importers, and regional price trends.Macroeconomic indicators, policy frameworks such as carbon pricing and energy security strategies, and evolving consumer behavior are considered in forecasting scenarios. Recent deal flows, partnerships, and technology innovations are incorporated to assess their impact on future market performance.
Benign Prostatic Hyperplasia (Bph) Treatment Devices and Equipment Market Competitive Intelligence
The competitive landscape is mapped through proprietary frameworks, profiling leading companies with details on business models, product portfolios, financial performance, and strategic initiatives. Key developments such as mergers & acquisitions, technology collaborations, investment inflows, and regional expansions are analyzed for their competitive impact. The report also identifies emerging players and innovative startups contributing to market disruption.Regional insights highlight the most promising investment destinations, regulatory landscapes, and evolving partnerships across energy and industrial corridors.
Countries Covered
- North America - Benign Prostatic Hyperplasia (Bph) Treatment Devices and Equipment market data and outlook to 2034
- United States
- Canada
- Mexico
- Europe - Benign Prostatic Hyperplasia (Bph) Treatment Devices and Equipment market data and outlook to 2034
- Germany
- United Kingdom
- France
- Italy
- Spain
- BeNeLux
- Russia
- Sweden
- Asia-Pacific - Benign Prostatic Hyperplasia (Bph) Treatment Devices and Equipment market data and outlook to 2034
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Malaysia
- Vietnam
- Middle East and Africa - Benign Prostatic Hyperplasia (Bph) Treatment Devices and Equipment market data and outlook to 2034
- Saudi Arabia
- South Africa
- Iran
- UAE
- Egypt
- South and Central America - Benign Prostatic Hyperplasia (Bph) Treatment Devices and Equipment market data and outlook to 2034
- Brazil
- Argentina
- Chile
- Peru
Research Methodology
This study combines primary inputs from industry experts across the Benign Prostatic Hyperplasia (Bph) Treatment Devices and Equipment value chain with secondary data from associations, government publications, trade databases, and company disclosures. Proprietary modeling techniques, including data triangulation, statistical correlation, and scenario planning, are applied to deliver reliable market sizing and forecasting.Key Questions Addressed
- What is the current and forecast market size of the Benign Prostatic Hyperplasia (Bph) Treatment Devices and Equipment industry at global, regional, and country levels?
- Which types, applications, and technologies present the highest growth potential?
- How are supply chains adapting to geopolitical and economic shocks?
- What role do policy frameworks, trade flows, and sustainability targets play in shaping demand?
- Who are the leading players, and how are their strategies evolving in the face of global uncertainty?
- Which regional “hotspots” and customer segments will outpace the market, and what go-to-market and partnership models best support entry and expansion?
- Where are the most investable opportunities - across technology roadmaps, sustainability-linked innovation, and M&A - and what is the best segment to invest over the next 3-5 years?
Your Key Takeaways from the Benign Prostatic Hyperplasia (Bph) Treatment Devices and Equipment Market Report
- Global Benign Prostatic Hyperplasia (Bph) Treatment Devices and Equipment market size and growth projections (CAGR), 2024-2034
- Impact of Russia-Ukraine, Israel-Palestine, and Hamas conflicts on Benign Prostatic Hyperplasia (Bph) Treatment Devices and Equipment trade, costs, and supply chains
- Benign Prostatic Hyperplasia (Bph) Treatment Devices and Equipment market size, share, and outlook across 5 regions and 27 countries, 2023-2034
- Benign Prostatic Hyperplasia (Bph) Treatment Devices and Equipment market size, CAGR, and market share of key products, applications, and end-user verticals, 2023-2034
- Short- and long-term Benign Prostatic Hyperplasia (Bph) Treatment Devices and Equipment market trends, drivers, restraints, and opportunities
- Porter’s Five Forces analysis, technological developments, and Benign Prostatic Hyperplasia (Bph) Treatment Devices and Equipment supply chain analysis
- Benign Prostatic Hyperplasia (Bph) Treatment Devices and Equipment trade analysis, Benign Prostatic Hyperplasia (Bph) Treatment Devices and Equipment market price analysis, and Benign Prostatic Hyperplasia (Bph) Treatment Devices and Equipment supply/demand dynamics
- Profiles of 5 leading companies - overview, key strategies, financials, and products
- Latest Benign Prostatic Hyperplasia (Bph) Treatment Devices and Equipment market news and developments
Additional Support
With the purchase of this report, you will receive:- An updated PDF report and an MS Excel data workbook containing all market tables and figures for easy analysis.
- 7-day post-sale analyst support for clarifications and in-scope supplementary data, ensuring the deliverable aligns precisely with your requirements.
- Complimentary report update to incorporate the latest available data and the impact of recent market developments.
This product will be delivered within 1-3 business days.
Table of Contents
1. Table of Contents
2. Global Benign Prostatic Hyperplasia (Bph) Treatment Devices And Equipment Market Summary, 2025
3. Benign Prostatic Hyperplasia (Bph) Treatment Devices And Equipment Market Insights, 2024-2034
4. Benign Prostatic Hyperplasia (Bph) Treatment Devices And Equipment Market Analytics
5. Global Benign Prostatic Hyperplasia (Bph) Treatment Devices And Equipment Market Statistics - Industry Revenue, Market Share, Growth Trends and Forecast by segments, to 2034
6. Asia Pacific Benign Prostatic Hyperplasia (Bph) Treatment Devices And Equipment Industry Statistics - Market Size, Share, Competition and Outlook
7. Europe Benign Prostatic Hyperplasia (Bph) Treatment Devices And Equipment Market Data, Penetration, and Business Prospects to 2034
8. North America Benign Prostatic Hyperplasia (Bph) Treatment Devices And Equipment Market Size, Growth Trends, and Future Prospects to 2034
9. South and Central America Benign Prostatic Hyperplasia (Bph) Treatment Devices And Equipment Market Drivers, Challenges, and Future Prospects
10. Middle East Africa Benign Prostatic Hyperplasia (Bph) Treatment Devices And Equipment Market Outlook and Growth Prospects
11. Benign Prostatic Hyperplasia (Bph) Treatment Devices And Equipment Market Structure and Competitive Landscape
12 Appendix
Companies Mentioned
- Karl Storz
- Lumenis Ltd.
- Olympus Corporation
- Urologix LLC
- Boston scientific Inc.
- Endo International PLC
- NeoTract Inc.
- OmniGuide Inc.
- Medifocus Inc.
- ProArc Medical Ltd.
- Teleflex Incorporated
- Medtronic PLC
- Urotech Devices
- Prostalund Operations AB
- Baxter International
- NxThera Inc.
- Richard Wolf GmbH
- Coloplast A/S
- Siemens Healthineers
- Quest Pharmatech
- Protox Therapeutics
- IntelGenx Technologies Corp
- Astellas Pharma Inc.
- Ipsen S.A.
- Biolitec AG
- BVM Medical
- Convergent Laser Technologies
- Cook Medical
- GreenLight Technologies
- Merit Medical Systems
- Pnn Medical A/S
- PROCEPT BioRobotics
- Prosenex
- ProSolv CardioVascular Inc.
- Quanta System
- Rocamed SAM
- RZ Medizintechnik GmbH
- SRS Medical Systems
- UroShape LLC
- Vertebron Inc.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 160 |
| Published | October 2025 |
| Forecast Period | 2025 - 2034 |
| Estimated Market Value ( USD | $ 2.3 Billion |
| Forecasted Market Value ( USD | $ 4.3 Billion |
| Compound Annual Growth Rate | 7.1% |
| Regions Covered | Global |
| No. of Companies Mentioned | 40 |
